Logo     Print Page  Close Window


SEC Filings


SC 13G
ANSON FUNDS MANAGEMENT LP filed this Form SC 13G on 06/01/2018
Entire Document
 
EX-99.1

EXHIBIT 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $.001 par value, of Fibrocell Science, Inc., a Delaware corporation, and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate.

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of June 1, 2018.

 

ANSON FUNDS MANAGEMENT LP
By: Anson Management GP LLC, its general partner
By:  

/s/ Bruce R. Winson

  Bruce R. Winson
  Manager
ANSON MANAGEMENT GP LLC
By:  

/s/ Bruce R. Winson

  Bruce R. Winson
  Manager

/s/ Bruce R. Winson

Bruce R. Winson
ANSON ADVISORS INC.
By:  

/s/ Amin Nathoo

  Amin Nathoo
  Director


By:  

/s/ Moez Kassam

  Moez Kassam
  Director

/s/ Amin Nathoo

Amin Nathoo

/s/ Moez Kassam

Moez Kassam

 

2